SynCardia Total Artifical Heart Patient Profile: Charles Okeke | CBS
2011 Bioscience Company of the Year, SynCardia Systems , Inc. is the privately-held manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart.
Brain State Technologies05/17/2013
Hockey's Kurt Sauer uses his brain to triumph over head injury.
Unconventional Brain Treatment Aiding Injured Phoenix Coyotes Defenseman Kurt Sauer The Arizona Republic | September 2011
SynCardia Systems, Inc.05/29/2013
Heart of a Champion - Justin Ryder
Former Semi-Pro Arena Football Player and Father of 3 Had Surgery for an Enlarged Heart at Age 18 Justin Ryder has battled heart problems nearly all his adult life. But after multiple surgeries, the 35-year-old Las Vegas, Nev., resident finally has a ticker that works - SynCardia's temporary Total Artificial Heart. Running out of options with his patched-up natural heart, Ryder had an artificial one implanted in early December at the University of Arizona Medical Center. It keeps him going, literally, while he awaits a donor heart.
Company Presentation: Invoy Technologies, LLC
Exhaled Breath: A Portal for Pain-Free Biochemical Analysis Invoy is engaged in the development and commercialization of breath analysis devices for a broad range of applications. Invoy plans to offer patients the ability to monitor their health in the convenience of their own home – with a prescription-based breath analysis device called the Voyager. The process is pain-free and the results are quick and accurate; giving patients peace of mind and confidence in using this new-to-the-market device.
Nasseo moves into the Fast Lane
Nasseo, Inc. is a start-up medical device company developing an implant surface modification technology to provide patients and clinicians with the next generation of dental and orthopedic implants. Over the past 18 months the company has achieved very impressive milestones and is in the Fast Lane to delivering a new platform technology that benefits patients in several compelling markets. In 2013 NASSEO was accepted into the BioInspire Medical Device accelerator in Peoria, AZ. In addition to mentoring and support, NASSEO received a $300,000 investment of seed funding from the highly competitive program. NASSEO was also named the 2013 Innovation Challenge Winner by the Arizona Commerce Authority (ACA) in its spring Arizona Innovation Challenge securing $250,000 for the commercialization of its first product, the TiArray™ Dental Implant which received FDA approval in 2013.